Pembrolizumab

TargetMol
Product Code: TAR-T9908
Product Group: Primary Antibodies
Supplier: TargetMol
CodeSizePrice
TAR-T9908-1mg1mg£259.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9908-2mg2mg£342.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9908-5mg5mg£506.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9908-10mg10mg£645.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T9908-25mg25mg£994.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Antibody Clonality: Monoclonal
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Further Information

Bioactivity:
Pembrolizumab is a humanized monoclonal antibody and the first in the class of agents called the HER2 dimerization inhibitors impairs the ability of HER2 to bind to other members of the HER family.
CAS:
1374853-91-4
Formula:
0
Molecular Weight:
149 kDa
Pathway:
Cell Cycle/Checkpoint; Apoptosis; Immunology/Inflammation
Purity:
0.98
SMILES:
0
Target:
PD-1/PD-L1

References

Garon EB, et al. Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med. 2015 May 21;372(21):2018-28. Khoja L, et al. Pembrolizumab. J Immunother Cancer. 2015 Aug 18;3:36.